Gail K. Naughton, Ph.D., Head, Dr. Naughton contributes invaluable knowledge and focus to Theregen's vascular and cardiovascular product development efforts. She is a world-recognized pioneer in cell-based regenerative medicine and holds more than 80 patents, including several in Theregen's IP portfolio. She has received a National Inventor of the Year award for her pioneering work in tissue engineering. She is currently Dean, School of Business Administration, San Diego State University, and serves on numerous advisory boards and boards of directors for both commercial and non-profit organizations.
Robert C. Robbins, M.D., Member, chairs the Department of Cardiothoracic Surgery of Stanford University.s School of Medicine, where he also serves as Director of the Stanford Cardiovascular Institute and Co-Director of the Cardiac Clinical Center at Stanford University Hospital. Dr. Robbins has extensive research experience in the area of congestive heart failure. He is a Fellow of the American Heart Association, American College of Cardiology and the American College of Surgery.
Stuart K. Williams, Ph.D., Member, brings extensive experience in cell-based regenerative medicine and cardiovascular therapeutics in his capacity as consultant and member of Theregen's Scientific Advisory Board. Dr.Williams is the scientific director of the Cardiovascular Innovation Institute, a partnership between the University of Louisville and Jewish Hospital & St. Mary's Health Care, and a professor in the Department of Surgery. He has extensive expertise in cardiovascular applications of biomedical devices and cell-based therapeutics. Dr. Williams serves as a Board member or scientific advisor to several companies.